Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 312

1.

Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD.

Singh D, Beeh KM, Colgan B, Kornmann O, Leaker B, Watz H, Lucci G, Geraci S, Emirova A, Govoni M, Nandeuil MA.

Respir Res. 2019 Aug 9;20(1):180. doi: 10.1186/s12931-019-1142-7.

2.

Transitional care of young people with juvenile idiopathic arthritis in Italy: results of a Delphi consensus survey.

Ravelli A, Sinigaglia L, Cimaz R, Alessio M, Breda L, Cattalini M, Consolaro A, Conti F, Cortis E, D'Angelo S, De Benedetti F, Doria A, Ferrari C, Gallizzi R, Govoni M, Gremese E, Iannone F, La Torre F, Maggio MC, Perricone R, Pontikaki I, Rossi F, Salaffi F, Simonini G, Caporali R; Italian Paediatric Rheumatology Study Group and the Italian Society of Rheumatology.

Clin Exp Rheumatol. 2019 Jul 25. [Epub ahead of print]

PMID:
31376254
3.

Finite-Field Approach to Solving the Bethe-Salpeter Equation.

Nguyen NL, Ma H, Govoni M, Gygi F, Galli G.

Phys Rev Lett. 2019 Jun 14;122(23):237402. doi: 10.1103/PhysRevLett.122.237402.

PMID:
31298883
4.

Analysis of HLA-G expression in renal tissue in lupus nephritis: a pilot study.

Foschi V, Bortolotti D, Doyle AF, Stratigou V, Stephens L, Trivedi P, Rinaldi R, Padovan M, Bortoluzzi A, Lightstone L, Cairns TD, Botto M, Cook TH, Rizzo R, Govoni M, Pickering MC.

Lupus. 2019 Aug;28(9):1091-1100. doi: 10.1177/0961203319860582. Epub 2019 Jul 10.

5.

The effect of gender on methotrexate prescription attitudes in Italian rheumatoid arthritis patients: the MARI study.

Giusti A, Epis OM, Migliore A, Ricioppo A, Sainaghi PP, Di Matteo L, Massarotti MS, Govoni M, Mazzone A, Traballi G, Ciarla S, Cozzi L, Roncaglione A, Muratore M, Laurenti R, Bianchi G.

Clin Exp Rheumatol. 2019 Jun 6. [Epub ahead of print]

PMID:
31172925
6.

Altered erythroid-related miRNA levels as a possible novel biomarker for detection of autologous blood transfusion misuse in sport.

Gasparello J, Lamberti N, Papi C, Lampronti I, Cosenza LC, Fabbri E, Bianchi N, Zambon C, Dalla Corte F, Govoni M, Reverberi R, Manfredini F, Gambari R, Finotti A.

Transfusion. 2019 Aug;59(8):2709-2721. doi: 10.1111/trf.15383. Epub 2019 May 30.

PMID:
31148196
7.

Brillouin micro-spectroscopy of subchondral, trabecular bone and articular cartilage of the human femoral head.

Cardinali MA, Dallari D, Govoni M, Stagni C, Marmi F, Tschon M, Brogini S, Fioretto D, Morresi A.

Biomed Opt Express. 2019 Apr 29;10(5):2606-2611. doi: 10.1364/BOE.10.002606. eCollection 2019 May 1.

8.

Real-world treatment persistence of golimumab in the management of immune-mediated rheumatic diseases in Europe: a systematic literature review.

Luttropp K, Dozier M, Justo N, Cornillie F, Kachroo S, Govoni M, Salomonsson S, Black CM, Khalifa A.

BMJ Open. 2019 May 28;9(5):e027456. doi: 10.1136/bmjopen-2018-027456.

9.

P2X7 Receptor Expression in Patients With Serositis Related to Systemic Lupus Erythematosus.

Furini F, Giuliani AL, Parlati ME, Govoni M, Di Virgilio F, Bortoluzzi A.

Front Pharmacol. 2019 Apr 29;10:435. doi: 10.3389/fphar.2019.00435. eCollection 2019.

10.

Concentration-QT Modeling Following Inhalation of the Novel Inhaled Phosphodiesterase-4 Inhibitor CHF6001 in Healthy Volunteers Shows an Absence of QT Prolongation.

Jolling K, Äbelö A, Luyckx N, Nandeuil MA, Govoni M, Cella M, Lindauer A.

CPT Pharmacometrics Syst Pharmacol. 2019 Jul;8(7):460-468. doi: 10.1002/psp4.12405. Epub 2019 May 11.

11.

Wireless Middleware Solutions for Smart Water Metering.

Alvisi S, Casellato F, Franchini M, Govoni M, Luciani C, Poltronieri F, Riberto G, Stefanelli C, Tortonesi M.

Sensors (Basel). 2019 Apr 18;19(8). pii: E1853. doi: 10.3390/s19081853.

12.

Treatment with golimumab or infliximab reduces health resource utilization and increases work productivity in patients with ankylosing spondylitis in the QUO-VADIS study, a large, prospective real-life cohort.

Claudepierre P, Van den Bosch F, Sarzi-Puttini P, Vastesaeger N, Govoni M, Kachroo S.

Int J Rheum Dis. 2019 Jun;22(6):995-1001. doi: 10.1111/1756-185X.13526. Epub 2019 Apr 15.

PMID:
30989813
13.

Metabolic activation triggered by cAMP in MCF-7 cells generates lethal vulnerability to combined oxamate/etomoxir.

Manerba M, Govoni M, Manet I, Leale A, Comparone A, Di Stefano G.

Biochim Biophys Acta Gen Subj. 2019 Jul;1863(7):1177-1186. doi: 10.1016/j.bbagen.2019.04.008. Epub 2019 Apr 11.

PMID:
30981740
14.

Editorial: Lupus and the Brain: Advances in Neuropsychiatric Systemic Lupus Erythematosus.

Fanouriakis A, Bertsias G, Govoni M.

Front Med (Lausanne). 2019 Mar 26;6:52. doi: 10.3389/fmed.2019.00052. eCollection 2019. No abstract available.

15.

Observational study on the QUality of life of Italian Axial SpondyloARthritis patients (QUASAR): baseline data.

D'Angelo S, Gilio M, D'Attino RM, Gualberti G, Merolla R, di Luzio Paparatti U, Malavolta N, Corvaglia S, Marchetta A, Scambi C, Romeo N, Pettiti G, Salvarani C, Catanoso MG, Scarpa R, Costa L, Ramonda R, Frallonardo P, Muratore M, Quarta L, Passiu G, Erre GL, Lubrano D, Tirri E, Govoni M, Furini F, Russo R, Buono R, Pozzi MR, Riva M, Grembiale RD, Bruno C, Gibertini P, Marchesoni A.

Clin Exp Rheumatol. 2019 Apr 2. [Epub ahead of print]

PMID:
30943145
16.

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.

Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, Cervera R, Doria A, Gordon C, Govoni M, Houssiau F, Jayne D, Kouloumas M, Kuhn A, Larsen JL, Lerstrøm K, Moroni G, Mosca M, Schneider M, Smolen JS, Svenungsson E, Tesar V, Tincani A, Troldborg A, van Vollenhoven R, Wenzel J, Bertsias G, Boumpas DT.

Ann Rheum Dis. 2019 Jun;78(6):736-745. doi: 10.1136/annrheumdis-2019-215089. Epub 2019 Mar 29.

PMID:
30926722
17.

Undifferentiated connective tissue disease: state of the art on clinical practice guidelines.

Antunes M, Scirè CA, Talarico R, Alexander T, Avcin T, Belocchi C, Doria A, Franceschini F, Galetti I, Govoni M, Hachulla E, Launay D, Lepri G, Macieira C, Matucci-Cerinic M, Montecucco CM, Moraes-Fontes MF, Mouthon L, Paolino S, Ramoni V, Tani C, Tas SW, Tincani A, Van Vollenhoven R, Zen M, Fonseca J, Bombardieri S, Fonseca JE, Schneider M, Smith V, Cutolo M, Mosca M, Beretta L.

RMD Open. 2019 Feb 26;4(Suppl 1):e000786. doi: 10.1136/rmdopen-2018-000786. eCollection 2018. Review.

18.

Ultrasonographic and Clinical Assessment of Peripheral Enthesitis in Patients with Psoriatic Arthritis, Psoriasis, and Fibromyalgia Syndrome: The ULISSE Study.

Macchioni P, Salvarani C, Possemato N, Gutierrez M, Grassi W, Gasparini S, Perricone C, Perrotta FM, Grembiale RD, Bruno C, Tripolino C, Govoni M, Ciancio G, Farina I, Ramonda R, Frallonardo P, Desiati F, Scarpa R, Costa L, Zabotti A, De Vita S, D'Attino RM, Gualberti G, Merolla R, di Luzio Paparatti U, Aldigeri R, Marchesoni A.

J Rheumatol. 2019 Aug;46(8):904-911. doi: 10.3899/jrheum.171411. Epub 2019 Mar 15.

19.

First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry).

Fredi M, Andreoli L, Bacco B, Bertero T, Bortoluzzi A, Breda S, Cappa V, Ceccarelli F, Cimaz R, De Vita S, Di Poi E, Elefante E, Franceschini F, Gerosa M, Govoni M, Hoxha A, Lojacono A, Marozio L, Mathieu A, Meroni PL, Minniti A, Mosca M, Muscarà M, Padovan M, Piga M, Priori R, Ramoni V, Ruffatti A, Tani C, Tonello M, Trespidi L, Zatti S, Calza S, Tincani A, Brucato A.

Front Cardiovasc Med. 2019 Feb 28;6:11. doi: 10.3389/fcvm.2019.00011. eCollection 2019.

20.

Rate of serious infections in spondyloarthropathy patients treated with anti-tumour necrosis factor drugs: a survey from the Italian registry GISEA.

Atzeni F, Sarzi-Puttini P, Sebastiani M, Panetta V, Salaffi F, Iannone F, Carletto A, Foti R, Gremese E, Govoni M, Marchesoni A, Favalli E, Gorla R, Ramonda R, Ferraccioli G, Lapadula G; GISEA group.

Clin Exp Rheumatol. 2019 Jul-Aug;37(4):649-655. Epub 2019 Feb 11.

PMID:
30767865
21.

Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome.

Bortoluzzi A, Piga M, Silvagni E, Chessa E, Mathieu A, Govoni M.

Lupus. 2019 Apr;28(4):465-474. doi: 10.1177/0961203319828499. Epub 2019 Feb 10.

PMID:
30739544
22.

Qresp, a tool for curating, discovering and exploring reproducible scientific papers.

Govoni M, Munakami M, Tanikanti A, Skone JH, Runesha HB, Giberti F, de Pablo J, Galli G.

Sci Data. 2019 Jan 29;6:190002. doi: 10.1038/sdata.2019.2.

23.

Complications and risk factors for severe outcome in children with measles.

Lo Vecchio A, Krzysztofiak A, Montagnani C, Valentini P, Rossi N, Garazzino S, Raffaldi I, Di Gangi M, Esposito S, Vecchi B, Melzi ML, Lanari M, Zavarise G, Bosis S, Valenzise M, Cazzato S, Sacco M, Govoni MR, Mozzo E, Cambriglia MD, Bruzzese E, Di Camillo C, Pata D, Graziosi A, Sala D, Magurano F, Villani A, Guarino A, Galli L; SITIP Measles Study Group.

Arch Dis Child. 2019 Jan 12. pii: archdischild-2018-315290. doi: 10.1136/archdischild-2018-315290. [Epub ahead of print]

PMID:
30636224
24.

Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies.

Andreoli L, Gerardi MC, Fernandes M, Bortoluzzi A, Bellando-Randone S, Brucato A, Caporali R, Chighizola CB, Chimenti MS, Conigliaro P, Cutolo M, Cutro MS, D'Angelo S, Doria A, Elefante E, Fredi M, Galeazzi M, Gerosa M, Govoni M, Iuliano A, Larosa M, Lazzaroni MG, Matucci-Cerinic M, Meroni M, Meroni PL, Mosca M, Patanè M, Pazzola G, Pendolino M, Perricone R, Ramoni V, Salvarani C, Sebastiani GD, Selmi C, Spinelli FR, Valesini G, Scirè CA, Tincani A.

Autoimmun Rev. 2019 Feb;18(2):164-176. doi: 10.1016/j.autrev.2018.08.008. Epub 2018 Dec 18. Review.

PMID:
30572134
25.

Systemic lupus erythematosus: state of the art on clinical practice guidelines.

Tamirou F, Arnaud L, Talarico R, Scirè CA, Alexander T, Amoura Z, Avcin T, Bortoluzzi A, Cervera R, Conti F, Cornet A, Devilliers H, Doria A, Frassi M, Fredi M, Govoni M, Houssiau F, Lladò A, Macieira C, Martin T, Massaro L, Moraes-Fontes MF, Pamfil C, Paolino S, Tani C, Tas SW, Tektonidou M, Tincani A, Van Vollenhoven RF, Bombardieri S, Burmester G, Eurico FJ, Galetti I, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Costedoat-Chalumeau N.

RMD Open. 2018 Nov 27;4(2):e000793. doi: 10.1136/rmdopen-2018-000793. eCollection 2018. Review.

26.

Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study.

Kamar N, Cassuto E, Piotti G, Govoni M, Ciurlia G, Geraci S, Poli G, Nicolini G, Mariat C, Essig M, Malvezzi P, Le Meur Y, Garrigue V, Del Bello A, Rostaing L.

Adv Ther. 2019 Feb;36(2):462-477. doi: 10.1007/s12325-018-0855-1. Epub 2018 Dec 14.

PMID:
30552587
27.

A Finite-Field Approach for GW Calculations beyond the Random Phase Approximation.

Ma H, Govoni M, Gygi F, Galli G.

J Chem Theory Comput. 2019 Jan 8;15(1):154-164. doi: 10.1021/acs.jctc.8b00864. Epub 2018 Dec 26.

PMID:
30521333
28.

Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy volunteers.

Mariotti F, Govoni M, Lucci G, Santoro D, Nandeuil MA.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 18;13:3399-3410. doi: 10.2147/COPD.S174156. eCollection 2018.

29.

The role of defects and excess surface charges at finite temperature for optimizing oxide photoabsorbers.

Gerosa M, Gygi F, Govoni M, Galli G.

Nat Mater. 2018 Dec;17(12):1122-1127. doi: 10.1038/s41563-018-0192-4. Epub 2018 Oct 29.

PMID:
30374203
30.

Coupling First-Principles Calculations of Electron-Electron and Electron-Phonon Scattering, and Applications to Carbon-Based Nanostructures.

McAvoy RL, Govoni M, Galli G.

J Chem Theory Comput. 2018 Dec 11;14(12):6269-6275. doi: 10.1021/acs.jctc.8b00728. Epub 2018 Nov 19.

PMID:
30351009
31.

Immediate treatment with tumour necrosis factor inhibitors in synthetic disease-modifying anti-rheumatic drugs-naïve patients with rheumatoid arthritis: results of a modified Italian Expert Consensus.

Bortoluzzi A, Valesini G, D'Angelo S, Frediani B, Bazzichi L, Afeltra A, Paolazzi G, Doria A, Meroni PL, Govoni M.

Rheumatology (Oxford). 2018 Oct 1;57(57 Suppl 7):vii32-vii41. doi: 10.1093/rheumatology/key076. Review.

PMID:
30289538
32.
33.
34.

Clinical and quality of life improvements with golimumab or infliximab in a real-life ankylosing spondylitis population: the QUO-VADIS study.

Van den Bosch F, Flipo RM, Braun J, Vastesaeger N, Kachroo S, Govoni M.

Clin Exp Rheumatol. 2019 Mar-Apr;37(2):199-207. Epub 2018 Jul 19.

PMID:
30148434
35.

The activation of lactate dehydrogenase induced by mTOR drives neoplastic change in breast epithelial cells.

Manerba M, Di Ianni L, Govoni M, Comparone A, Di Stefano G.

PLoS One. 2018 Aug 23;13(8):e0202588. doi: 10.1371/journal.pone.0202588. eCollection 2018.

36.

Epigallocatechin-3-gallate and 6-OH-11-O-Hydroxyphenanthrene Limit BE(2)-C Neuroblastoma Cell Growth and Neurosphere Formation In Vitro.

Farabegoli F, Govoni M, Spisni E, Papi A.

Nutrients. 2018 Aug 22;10(9). pii: E1141. doi: 10.3390/nu10091141.

37.

Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs.

Maritati M, Trentini A, Michel G, Bellini T, Almugadam S, Hanau S, Govoni M, Marty P, Contini C.

Infection. 2018 Dec;46(6):801-809. doi: 10.1007/s15010-018-1189-2. Epub 2018 Aug 10.

PMID:
30097989
38.

Communication: Dielectric properties of condensed systems composed of fragments.

Pan D, Govoni M, Galli G.

J Chem Phys. 2018 Aug 7;149(5):051101. doi: 10.1063/1.5044636.

PMID:
30089393
39.

Entheseal involvement in asymptomatic human immunodeficiency virus infected patients: preliminary results of a clinical and ultrasonographic study.

Ciancio G, Sighinolfi L, Furini F, Segala D, Farina I, Galuppi E, De Stefani E, Simone L, Boccia S, Grilli A, Pazzi P, Libanore M, Contini C, Govoni M.

Clin Exp Rheumatol. 2018 Sep-Oct;36(5):862-870. Epub 2018 May 24.

PMID:
29846159
40.

Peripheral nervous system involvement in systemic lupus erythematosus: a review of the evidence.

Bortoluzzi A, Silvagni E, Furini F, Piga M, Govoni M.

Clin Exp Rheumatol. 2019 Jan-Feb;37(1):146-155. Epub 2018 May 24. Review.

41.

Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset.

Sebastiani GD, Prevete I, Iuliano A, Piga M, Iannone F, Coladonato L, Govoni M, Bortoluzzi A, Mosca M, Tani C, Doria A, Iaccarino L, Tincani A, Fredi M, Conti F, Spinelli FR, Galeazzi M, Bellisai F, Zanetti A, Carrara G, Scirè CA, Mathieu A.

Lupus. 2018 Aug;27(9):1479-1488. doi: 10.1177/0961203318777112. Epub 2018 May 19.

PMID:
29779436
42.

The effects of blood transfusion on red blood cell distribution width in critically ill patients: a pilot study.

Spadaro S, Taccone FS, Fogagnolo A, Franchi F, Scolletta S, Ragazzi R, Fanni A, Marangoni E, Govoni M, Reverberi R, Volta CA.

Transfusion. 2018 Aug;58(8):1863-1869. doi: 10.1111/trf.14759. Epub 2018 May 16.

PMID:
29770452
43.

Correction to: Regional differences in baseline disease activity and remission rates following golimumab treatment for RA: results from the GO-MORE trial.

Durez P, Pavelka K, Lazaro MA, Garcia-Kutzbach A, Moots RJ, Amital H, Govoni M, Vastesaeger N.

Clin Rheumatol. 2018 Jul;37(7):2017-2018. doi: 10.1007/s10067-018-4131-1.

PMID:
29752584
44.

Regional differences in baseline disease activity and remission rates following golimumab treatment for RA: results from the GO-MORE trial.

Durez P, Pavelka K, Lazaro MA, Garcia-Kutzbach A, Moots RJ, Amital H, Govoni M, Vastesaeger N.

Clin Rheumatol. 2018 May;37(5):1417-1420. doi: 10.1007/s10067-018-4074-6. Epub 2018 Apr 2. Erratum in: Clin Rheumatol. 2018 May 12;:.

PMID:
29611083
45.

Attribution of Neuropsychiatric Manifestations to Systemic Lupus Erythematosus.

Bortoluzzi A, Scirè CA, Govoni M.

Front Med (Lausanne). 2018 Mar 14;5:68. doi: 10.3389/fmed.2018.00068. eCollection 2018. Review.

46.

Changes in hemoglobin profile reflect autologous blood transfusion misuse in sports.

Lamberti N, Finotti A, Gasparello J, Lampronti I, Zambon C, Cosenza LC, Fabbri E, Bianchi N, Dalla Corte F, Govoni M, Reverberi R, Gambari R, Manfredini F.

Intern Emerg Med. 2018 Jun;13(4):517-526. doi: 10.1007/s11739-018-1837-7. Epub 2018 Mar 23.

PMID:
29572786
47.

Multifocal Skin Tuberculosis: Report of A Case.

Malaventura C, Bulian A, Cacciatore E, Fiumana E, Govoni MR, Maggiore G, Borgna-Pignatti C.

Pediatr Infect Dis J. 2018 Dec;37(12):e347-e349. doi: 10.1097/INF.0000000000002022.

PMID:
29570177
48.

Risk factors associated with complications/sequelae of acute and subacute haematogenous osteomyelitis: an Italian multicenter study.

Chiappini E, Krzysztofiak A, Bozzola E, Gabiano C, Esposito S, Lo Vecchio A, Govoni MR, Vallongo C, Dodi I, Castagnola E, Rossi N, Valentini P, Cardinale F, Salvini F, Bona G, Bossi G, Olivieri AN, Russo F, Fossali E, Bottone G, Dellepiane M, De Martino M, Villani A, Galli L.

Expert Rev Anti Infect Ther. 2018 Apr;16(4):351-358. doi: 10.1080/14787210.2018.1453357. Epub 2018 Mar 29.

PMID:
29569505
49.

GW100: Comparison of Methods and Accuracy of Results Obtained with the WEST Code.

Govoni M, Galli G.

J Chem Theory Comput. 2018 Apr 10;14(4):1895-1909. doi: 10.1021/acs.jctc.7b00952. Epub 2018 Mar 15.

PMID:
29397712
50.

Electron affinity of liquid water.

Gaiduk AP, Pham TA, Govoni M, Paesani F, Galli G.

Nat Commun. 2018 Jan 16;9(1):247. doi: 10.1038/s41467-017-02673-z.

Supplemental Content

Loading ...
Support Center